A Trial of the Irradiance Level of Phototherapy for Neonatal Jaundice

NCT ID: NCT03055481

Last Updated: 2023-10-03

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

TERMINATED

Clinical Phase

NA

Total Enrollment

100 participants

Study Classification

INTERVENTIONAL

Study Start Date

2017-07-01

Study Completion Date

2022-01-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The aim of this trial is to show that the low irradiance level is not worse than the high irradiance level in the phototherapy for neonatal jaundice.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Neonatal jaundice is a commonly disease. Phototherapy is performed to prevent from kernicterus.However, light sources and irradiance level are different among hospitals, and it was controversial whether the improvement of jaundice is related to the irradiance level of phototherapy or not. In addition, long-term side effects are not clear, therefore, excessive irradiation should be avoided. The purpose of this study is to show that the low irradiance level is not worse than the high irradiance level in the phototherapy for neonatal jaundice. This study is multicenter randomized controlled trial conducted by Nagoya University Hospital, Anjo Kosei Hospital, Kasugai Municipal Hospital, Handa Hospital, TOYOTA Memorial Hospital, National Hospital Organization Nagoya Medical Center, Japan Red Cross Nagoya Daiichi Hospital, Hekinan Municipal Hospital, and Ogaki Municipal Hospital.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Neonatal Jaundice

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

High level irradiation

High level irradiation: the target irradiance level is 30-35uW per square centimeter per nano-meter of wavelength.

Group Type ACTIVE_COMPARATOR

High irradiance level of phototherapy

Intervention Type OTHER

High irradiance level of phototherapy: the target irradiance level is 30-35uW per square centimeter per nanometer of wavelength.

Low level irradiation

Low level irradiation: the target irradiance level is 12-15uW per square centimeter per nano-meter of wavelength.

Group Type EXPERIMENTAL

Low irradiance level of phototherapy

Intervention Type OTHER

Low irradiance level of phototherapy: the target irradiance level is 12-15uW per square centimeter per nanometer of wavelength

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

High irradiance level of phototherapy

High irradiance level of phototherapy: the target irradiance level is 30-35uW per square centimeter per nanometer of wavelength.

Intervention Type OTHER

Low irradiance level of phototherapy

Low irradiance level of phototherapy: the target irradiance level is 12-15uW per square centimeter per nanometer of wavelength

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Asian full-term neonates with jaundice between 48 and 96 hours of age.

Exclusion Criteria

* Patients with low-birth-weight, early onset jaundice before 48 hours of age, perinatal asphyxia, antimicrobial therapy or respiratory disorders. Patients with jaundice caused by hemolysis, or functional or anatomic obstruction. Patients who need treatments except for phototherapy.
Minimum Eligible Age

2 Days

Maximum Eligible Age

4 Days

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Nagoya University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Yoshiaki Sato

Associate professor

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Anjo Kosei Hospital

Anjo, Aichi-ken, Japan

Site Status

Handa City Hospital

Handa, Aichi-ken, Japan

Site Status

Hekinan Municipal Hospital

Hekinan, Aichi-ken, Japan

Site Status

Kasugai Municipal Hospital

Kasugai, Aichi-ken, Japan

Site Status

Japan Red Cross Nagoya Daiichi Hospital

Nagoya, Aichi-ken, Japan

Site Status

Nagoya University Hospital

Nagoya, Aichi-ken, Japan

Site Status

TOYOTA Memorial Hospital

Toyota, Aichi-ken, Japan

Site Status

Ogaki Municipal Hospital

Ōgaki, Gifu, Japan

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Japan

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2016-04-8

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Bone Disease in Severely Burned Children
NCT00591162 TERMINATED PHASE2/PHASE3
Photoscreening for Retinoblastoma
NCT04344652 WITHDRAWN NA